Skip to main content

John Burcham, Terrie Pizzie, Mathias Uhln, and Eric Lander

Premium

John Burcham has joined Applied Biosystems as senior marketing manager for TaqMan SNP genotyping assays, GenomeWeb News has learned. He came to ABI from GE Healthcare, formerly Amersham, where he was strategic marketing manager for proteomics. Prior to that, he held technical specialist and marketing positions at Bio-Rad. Burcham holds a BA from the University of California, Berkeley.


Terrie Pizzie will become senior vice president of commercial operations at Biacore International starting March 1, the company said last week. Prior to joining the company, he was vice president Europe of Applied Biosystems. Before that, he was ABI’s director of sales and marketing in Europe.


Mathias Uhlén will receive this year’s Akzo Nobel science award on March 15, the Netherlands-based company said last week. He is a professor at the Royal Institute of Technology in Stockholm, Sweden. Uhlén receives the 500,000 Swedish kronor ($72,600) award “for his unique research in the field of biotechnology and his ability to bridge research and industry,” according to Akzo. He founded a number of biotechnology companies, including Pyrosequencing, Affibody, Creative Peptides, SweTree Genomics, and Visual Bioinformatics. Uhlén also initiated a project at his institute to map 22,000 human proteins. The Akzo Nobel science award alternates between Sweden and the Netherlands every year.


Eric Lander will receive this year’s Public Understanding of Science and Technology award from the American Association for the Advancement of Science, AAAS said last week. He is the founding director of the Broad Institute of MIT and Harvard and a professor of biology at MIT, a professor of systems biology at Harvard Medical School, and a member of the Whitehead Institute for Biomedical Research. Lander holds a PhD in mathematics from Oxford University and an undergraduate degree in mathematics from Princeton University.

 

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.